Vivace Therapeutics Inc.

The number of venture capital mega-rounds of $100m or more plummeted from 11 in January to just three in February, but appear to be on the rise again with five as of mid-March. Flagship Pioneering’s l

Biopharmaceutical companies developing therapies for neurological diseases are in the midst of a boom, not only in terms of novel approaches to treating intractable diseases but also in terms of attra

City of Hope Licenses CTLX-CAR-T Candidate To Chimeric Independent research and treatment center City of Hope National Medical Center said on 21 September that it has licensed intellectual property

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging bio